LEXX - Income Statement - Lexaria Bioscience Corp.

	Aug-2024	Aug-2023	Aug-2022	Aug-2021	Aug-2020	Aug-2019	Aug-2018	Aug-2017	Aug-2016	Aug-2015	Aug-2014	Oct-2012	Oct-2011	Oct-2010	Oct-2009	Oct-2008	Oct-2007	Oct-2006	Oct-2005
REVENUE
Revenue	0.5	0.2	0.3	0.7	0.4	0.2	0.4	63.6 K	40.7 K	14.7 K	1.1	1.4	1.1	0.4	0.4	0.9	0.3	20.3 K	20.3 K
GROSS PROFIT
Cost Of Revenue	4.82 K	31.5 K	71.8 K	0.2	99.4 K	22.9 K	25.2 K	29.8 K	45.6 K	29.9 K	0.8	0.8	0.7	0.3	0.5	0.9	0.1	93.3 K	93.3 K
Gross Profit	0.5	0.2	0.2	0.5	0.3	0.2	0.4	33.9 K	4.9 K	15.2 K	0.3	0.6	0.5	88.9 K	(0.1)	12 K	0.1	73 K	73 K
OPERATING INCOME
Operating Expenses	6.2	6.7	7.6	6.2	4.3	4.3	7.0	1.9	1.2	1.9	8.19 K	0.6	0.7	0.5	0.5	0.5	1.2	0.1	35.1 K
Selling, General and Administrative Expenses	3.9	3.1	5.7	5.0	3.8	3.6	6.5	1.8	1.2	1.8	8.19 K	0.6	0.7	0.5	0.5	0.5	1.0	0.1	35.1 K
Research and Development Expenses	2.4	3.7	1.8	1.3	0.4	0.6	0.5	54.2 K	9.02 K	0.1	0	0	0	0	0	0	0	0	0
Operating Income	(5.8)	(6.5)	(7.4)	(5.7)	(3.9)	(4.0)	(6.6)	(1.9)	(1.2)	(1.9)	0.3	4.9 K	(0.3)	(0.6)	(0.8)	(0.9)	(1.1)	(0.5)	35.1 K
PRE-TAX INCOME
Interest Income Expense	0	0	0	0	0	0	0	6.02 K	2.25 K	31.5 K	0.3	0.2	0.3	0.2	0.2	0.9	4.71 K	21.9 K	21.9 K
Total Other Income	55.5 K	(0.2)	(0.8)	1.5	0	(0.2)	8.97 K	6.02 K	34.7 K	55.1 K	(0.4)	(0.2)	(0.3)	(0.3)	0	7.05 K	73.3 K	(0.6)	(0.5)
Pre-Tax Income	(5.8)	(6.7)	(7.4)	(4.2)	(4.1)	(4.2)	(6.6)	(1.9)	(1.3)	(2.0)	(1.9)	(0.3)	(0.5)	(0.6)	(0.8)	(1.0)	(1.1)	(0.2)	75.6 K
NET INCOME
Tax Provision	0	0	(0.1)	(1.7)	54.3 K	39.6 K	8.97 K	54.2 K	60.2 K	(0.2)	0.3	0.2	0.3	0.2	94	7.14 K	1.04 K	0.6	40.6 K
Net Income	(5.8)	(6.7)	(7.3)	(2.5)	(4.0)	(4.2)	(6.6)	(1.9)	(1.2)	(1.8)	(1.9)	(0.3)	(0.5)	(0.6)	(0.8)	(1.0)	(1.1)	(0.5)	75.7 K
EPS	0.47	1.01	1.24	0.57	1.45	1.62	2.79	0.95	0.83	1.34	0.0728	0.42	1.09	1.22	2.8	4.46	5.21	3.16	1.37

Free